Announcements Trials
Browse Landscape

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 1NIH 1INDUSTRY 1

Study Type

Interventional 13Observational 3Expanded_access 1

Sponsor

Cancer Type

Sarcoma 3Gastrointestinal 3Thoracic 1Head & Neck 1Gynecologic 1Genitourinary 1Dermatologic 1

Conditions

Breast Neoplasms 109Neoplasms 108Lung Neoplasms 66Prostatic Neoplasms 57Colorectal Neoplasms 48Carcinoma, Non-Small-Cell Lung 44Pancreatic Neoplasms 31Hematologic Neoplasms 28Multiple Myeloma 23Leukemia, Myeloid, Acute 23Stomach Neoplasms 21Ovarian Neoplasms 21Carcinoma, Hepatocellular 21Brain Neoplasms 21Lymphoma 20Melanoma 19Esophageal Neoplasms 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Disease 18Urinary Bladder Neoplasms 17Colonic Neoplasms 16Uterine Cervical Neoplasms 15Liver Neoplasms 15Leukemia, Lymphocytic, Chronic, B-Cell 15Head and Neck Neoplasms 14Endometrial Neoplasms 14Lymphoma, Non-Hodgkin 13Leukemia 13Kidney Neoplasms 13Carcinoma, Renal Cell 13

Interventions

trastuzumab deruxtecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Gastrointestinal Stromal Tumors × 30 days × Clear all
NCT07124000 2026-06-01

DP-04

AstraZeneca

Recruiting
100 enrolled
DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Adenocarcinoma, Anus Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Melanoma, Mouth Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Testicular Neoplasms, Thyroid Neoplasms, Urethral Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Gastrointestinal Stromal Tumors, Small Cell Lung Carcinoma

NCT04557969 2026-05-29

Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis

National Institutes of Health Clinical Center (CC)

Recruiting
400 enrolled
GastrointestinalSarcoma

Stomach Neoplasms, Gastrointestinal Stromal Tumors

NCT07614841 2026-05-29

To Explore the Optimal Therapeutic Window for Imatinib in the Adjuvant Treatment of Intermediate and High-risk Gastrointestinal Stromal Tumors

First Affiliated Hospital, Sun Yat-Sen University

Completed
328 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡